Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06106646 · ClinicalTrials.gov registry record
Vitamin C to Decrease Effects of Smoking in Pregnancy on Infant Lung Function (VCSIP) Longer Term Follow Up
A clinical trial of Asthma and Wheezing, sponsored by Oregon Health and Science University.
- Recruiting
- Registry status
- 225
- Enrollment target
- 2
- Study locations
NCT06106646 is a study of Asthma and Wheezing that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 225 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (86% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT06106646, a study of Asthma and Wheezing, is actively recruiting participants, sponsored by Oregon Health and Science University.
- RECRUITING
- Registry status
- 225 participants
- Enrollment target
- 2
- Study locations
Study Summary
The overall aims of this protocol are to determine whether prenatal supplementation with vitamin C to pregnant smokers can improve pulmonary function at 10 years of age in their offspring. This is an additional continuation of the Vitamin C to Decrease Effects of Smoking in Pregnancy on Infant Lung Function (VCSIP) trial, to follow the offspring through 10 years of age. The hypothesis for this protocol is an extension of the VCSIP trial that supplemental vitamin C in pregnant smokers can significantly improve their children's airway function tests. The investigators aim to demonstrate sustained improvement in airway/pulmonary function and trajectory through 10 years of age.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT No active intervention in this protocol (previously randomized to Vitamin C)
- OTHER No active intervention in this protocol (previously randomized to Placebo)
Study Locations (2)
Indiana
- Indiana University - Indianapolis
Oregon
- Oregon Health and Science University (OHSU) - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 225 participants |
| Start Date | 2023-10-11 |
| Est. Completion | 2028-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06106646
The ClinicalTrials.gov registry entry for NCT06106646 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 225 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (86% lower). The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Asthma appearing as the primary indexed condition, and to 2 interventions - of which No active intervention in this protocol (previously randomized to Vitamin C) is the first listed.
NCT06106646 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Indiana, Oregon.
Frequently Asked Questions
What is clinical trial NCT06106646 about?
NCT06106646 is a clinical study titled "Vitamin C to Decrease Effects of Smoking in Pregnancy on Infant Lung Function (VCSIP) Longer Term Follow Up". The overall aims of this protocol are to determine whether prenatal supplementation with vitamin C to pregnant smokers can improve pulmonary function at 10 years of age in their offspring. This is an additional continuation of the Vitamin C to Decrease Effects of Smoking in Pregnancy on Infant Lung ...
What is the current status of trial NCT06106646?
This trial is currently recruiting. The enrollment target is 225 participants. The study started on 2023-10-11. Estimated completion is 2028-08.
What conditions does trial NCT06106646 study?
This clinical trial studies the following conditions: Asthma, Wheezing, Pulmonary Function, In Utero Nicotine.
What interventions are being tested in trial NCT06106646?
The interventions under investigation include: No active intervention in this protocol (previously randomized to Vitamin C) (DIETARY_SUPPLEMENT), No active intervention in this protocol (previously randomized to Placebo) (OTHER).
Who is sponsoring clinical trial NCT06106646?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06106646 being conducted?
This trial has 2 study locations across Indiana, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Innate Immunity in Allergic Asthma
RECRUITING
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Impact of Metabolic Dysfunction and Mucus Plugging on Asthma Physiology
RECRUITING
-
Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
RECRUITING · Phase 3
-
Escitalopram in Asthma Patients With Frequent Exacerbation
RECRUITING · Phase 2
-
Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.